4BB vs 8EV: Side-by-Side Comparison
Compare 4BASEBIO UK SOCIETAS (4BB) and EVGEN PHARMA PLC LS-0025 (8EV) side by side: market cap GBX 8.13B vs EUR 5.29M. Financials, growth and model signals on Bullrun.
| Metric | 4BB | 8EV |
|---|---|---|
| Company | 4BASEBIO UK SOCIETAS | EVGEN PHARMA PLC LS-0025 |
| Country / Exchange | United Kingdom · LSE | United Kingdom · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | GBX 8.13B | EUR 5.29M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | GBP 933.00K | EUR 0 |
| Revenue growth YoY | +84.4% | -100.0% |
| Net income | GBP -12.33M | EUR -1.94M |
| Gross margin | 67.5% | — |
| Diluted EPS | -0.94 | -0.00 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.